Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Structured treatment interruptions to control HIV-1 and limit drug exposure
Autore:
Montaner, LJ;
Indirizzi:
Wistar Inst, Philadelphia, PA 19104 USA Wistar Inst Philadelphia PA USA 19104 ar Inst, Philadelphia, PA 19104 USA
Titolo Testata:
TRENDS IN IMMUNOLOGY
fascicolo: 2, volume: 22, anno: 2001,
pagine: 92 - 96
SICI:
1471-4906(200102)22:2<92:STITCH>2.0.ZU;2-K
Fonte:
ISI
Lingua:
ENG
Soggetto:
ACTIVE ANTIRETROVIRAL THERAPY; T-CELL RESPONSES; IMMUNODEFICIENCY VIRUS-INFECTION; PROLONGED VIRAL SUPPRESSION; IMMUNE-RESPONSES; PROTEASE INHIBITORS; ANTIVIRAL THERAPY; TYPE-1 INFECTION; CD4(+); LYMPHOCYTES;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
43
Recensione:
Indirizzi per estratti:
Indirizzo: Montaner, LJ Wistar Inst, 3601 Spruce St, Philadelphia, PA 19104 USA Wistar Inst 3601 Spruce St Philadelphia PA USA 19104 9104 USA
Citazione:
L.J. Montaner, "Structured treatment interruptions to control HIV-1 and limit drug exposure", TRENDS IMMU, 22(2), 2001, pp. 92-96

Abstract

Although therapy-mediated suppression of HIV-1 is effective and results ina degree of immune reconstitution, the complications resulting from life-long treatment emphasize the need for alternatives, This review discusses the use of structured interruptions in antiviral therapy to induce drug-free periods of immune-mediated control of HIV-1, Such an approach has the ultimate objective of harnessing anti-viral immune responses, reducing drug exposure (toxicity end cost) and potentially extending the clinical benefits ofa suppressive treatment regimen.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/04/20 alle ore 07:01:44